PATENT CLAIM ANALYSIS

Application Number: 15745290
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["514", "300000"]

Abstract:
The present invention provide a heterocyclic compound having a HDAC inhibitory action, and useful for the treatment of autoimmune diseases and/or inflammatory diseases, graft versus host disease, cancers, central nervous diseases including neurodegenerative diseases, Charcot-Marie-Tooth disease and the like, and a medicament comprising the compound. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.

Claim (Index 12):
The compound or salt according to  claim 1  for use in the prophylaxis or treatment of neurodegenerative diseases.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 86.0
- Lexical Diversity: 1.46429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15754934', '15506380', '15210965', '13522070', '13522044']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7801692893745069
- 35 USC 102 Novelty (BERT): 0.5448181865988061
- Combined Prediction Score: 0.7566341790969369
- Mean Citation Score: 344.54181
- Max Citation Score: 379.56735
- Similarity Product: 265.25400463643075

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test